It's a very long story indeed and far longer than a single comment could encompass! MAPS, and several other incredible organizations, have been working for decades to push psychedelic research through the steep financial and regulatory requirements involved in the onerous clinical research process. The primary compounds being studied are MDMA, LSD, psilocybin, and ketamine, for a wide variety of different clinical applications varying from treating PTSD to depression to OCD to end-of-life anxiety. We've been keen observers as this research has evolved and excited for the implications for so many that are suffering... but also have watched the enthusiasm for these treatments spill over into people trying out less-than-safe DIY applications in home and other unlicensed environments.

We're a big fan of Michael Pollan's book, "How To Change Your Mind", for a deep dive into the history of use of these compounds and how regulation and clinical research has evolved over the last century. From his website: https://michaelpollan.com/books/how-to-change-your-mind/ Amazon purchase link: https://amzn.to/3swCUEW

If you're not looking for a whole book, but would rather like to stay up to date on the clinical research as it emerges, Lucid News has as great weekly newsletter that sums up the headlines with the latest and greatest in clinical research developments: https://www.lucid.news/